Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 270 participants.

Also called NCT05750576

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose other
Phase
Not applicable
Enrolled
  • 270 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT05750576
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT05750576. Randomized; no masking; primary purpose other. Start 2023-06-15 (actual); primary completion 2025-06-20 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Impact of ECMO Cannula Chlorhexidine-impregnated Dressings to Decrease Extracorporeal Membrane Oxygenation-cannula Related Infection Rate
Acronym
DRESSING-ECMO
Condition
Cardiogenic Shock
Condition
Extracorporeal Membrane Oxygenation Complication
Condition
Acute Respiratory Distress Syndrome
Condition
Infections
Intervention (Device)
Chlorhexidine-impregnated dressings
Intervention (Device)
Non impregnated dressings
Lead sponsor
Assistance Publique - Hôpitaux de Paris (class: other)

Record details

Record id
cardio:ct-nct05750576
Content hash
01637a94b14543366575662de3d616bff0fd45738ca0146a50f5842b46c438ec